ArticleDiabetes research and clinical practice2022

Association of formulary restrictions and initiation of an SGLT2i or GLP1-RA among Medicare beneficiaries with type 2 diabetes.

Jing Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.